TNFSF10 and cancer: The fact that exogenously added TRAIL specifically induces cancer cell death with low toxicity to normal cells [49,50] led to the development of anticancer therapies modulating the interaction between TRAIL protein and TRAIL receptors to selectively kill cancer cells.